" class="no-js "lang="en-US"> Hayylo - Medtech Alert
Friday, August 01, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Hayylo | Pharmtech Focus

Hayylo

About Hayylo

Hayylo

We exist to help foster better connections between healthcare providers and their customers.

Hayylo is an end-to-end solution. Born to help healthcare providers break down communication gaps that exist between care providers and their customers and focused on empowering our clients to service their customers better than ever before.

Related Story

Health Apps

 Telstra Health and Hayylo Partner to Streamline Aged Care and Disability Client Interactions | Pharmtech Focus

Telstra Health and Hayylo Partner to Streamline Aged Care and Disability Client Interactions

August 6 2021

Telstra Health has partnered with Hayylo, a homegrown award winning software platform, to simplify digital […]